Where pharma and funds converge
As the global business landscape continues to evolve and intertwine, the corporate ecosystem constantly reveals similarities in operations among industries. So, although it may seem unusual to compare the investment fund and pharmaceutical sectors, a deeper analysis reveals surprising similarities.
In this white paper, Annick Breton – Partner and Head of Consulting – explores these parallels and provides insights into how they operate. This study aims to examine the dynamics of these two distinct sectors – pharmaceuticals and investment funds – and shares an outlook into how these industries can overcome their current obstacles.
Despite having different objectives, both industries face significant challenges in maintaining consumer confidence, intensified by recent major crises. Annick’s analysis delves into the impact of regulation and technology on consumer protection and industry growth. By demonstrating the complex ecosystems of both sectors, we uncover not only the common challenges, but also the similar opportunities that they share.
Curious about the dynamic connection between these two industries? Hear directly from industry experts in our exclusive two-episode series of Conversations, powered by KPMG Luxembourg. Tune in now!
